RankAlpha logo
Back to Rankings

ENTX

Entera BioF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
ENTX vs peer average
29/100
ENTX vs. peer average (F vs. D)
Grade spread
B 2 · C 2 · D 3 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ATOS is the first available peer comparator.

Loose same-sector, similar-market-cap biotech comparator from the packet; useful only for financing sensitivity and binary clinical-event volatility, not as a direct osteoporosis or oral-peptide peer.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerATOSAtossa Therapeutics
ENTX
Entera Bio
ATOS
Atossa Therapeutics
Grade
F
F
Momentum
98
2
Value
41
41
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs ATOS

ENTX / ATOS
Grade Position
Below peers
ENTX vs. peer average (F vs. D)
29/100
Momentum
98
ENTX
Value
41
ENTX
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ENTX
1
ATOS
ATOS
F
20/100
Even
2
PLRX
PLRX
B
80/100
-3
3
RLMD
Relmada Therapeutics Inc Common
C
60/100
-2
4
EOLS
Evolus Inc Common
B
80/100
-3
5
CABA
Cabaletta Bio Inc Common
D
40/100
-1
ATOS is the first peer returned for this comparison set.